Single-cell RNA sequencing of blood immune cells reveals type I interferon-associated hyper-inflammation in severe COVID-19. Although most SARS-CoV-2-infected individuals experience mild coronavirus disease 2019 (COVID-19), some patients suffer from severe COVID-19, which is accompanied by acute respiratory distress syndrome and systemic inflammation. To identify factors driving severe progression of COVID-19, we performed single-cell RNA-seq using peripheral blood mononuclear cells (PBMCs) obtained from healthy donors, patients with mild or severe COVID-19, and patients with severe influenza. Patients with COVID-19 exhibited hyper-inflammatory signatures across all types of cells among PBMCs, particularly up-regulation of the TNF/IL-1β-driven inflammatory response as compared to severe influenza. In classical monocytes from patients with severe COVID-19, type I IFN response co-existed with the TNF/IL-1β-driven inflammation, and this was not seen in patients with milder COVID-19. Interestingly, we documented type I IFN-driven inflammatory features in patients with severe influenza as well. Based on this, we propose that the type I IFN response plays a pivotal role in exacerbating inflammation in severe COVID-19.
【초록키워드】 COVID-19, coronavirus disease, Inflammation, severe COVID-19, Influenza, progression, Peripheral blood, RNA sequencing, single-cell RNA-seq, Patient, Mild, hyper-inflammation, systemic inflammation, acute respiratory distress, Inflammatory response, Inflammatory, PBMCs, Type I IFN, mononuclear cell, Factor, healthy donors, type I, syndrome, driving, feature, Cell, identify, performed, exhibited, reveal, accompanied, blood immune cell, classical monocyte, exacerbating, SARS-CoV-2-infected individual, with COVID-19, 【제목키워드】 COVID-19, severe COVID-19, Influenza, type I interferon, Immunophenotyping, highlight,